Thursday, October 26, 2006 11:00 IST Cambridge, Massachusetts
Alantos Pharmaceuticals, a privately held biopharmaceutical company based on the discovery and development of small molecule drugs with a focus on type II diabetes and osteoarthritis/inflammation